These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9205743)
1. Study on the increment of the amount of gastric mucus in rats after repeated-dose administration of ebrotidine. Romero A; Villamayor F; Palop D; Falcó J; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):455-8. PubMed ID: 9205743 [TBL] [Abstract][Full Text] [Related]
2. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat. Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740 [TBL] [Abstract][Full Text] [Related]
3. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists. Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742 [TBL] [Abstract][Full Text] [Related]
4. Gastroprotective properties of ebrotidine. A review. Slomiany BL; Piotrowski J; Slomiany A Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744 [TBL] [Abstract][Full Text] [Related]
5. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review. Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769 [TBL] [Abstract][Full Text] [Related]
6. Involvement of endogenous nitric oxide and sulfhydryl compounds in ebrotidine-induced gastroprotection. Palop D; Conejo L; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):468-71. PubMed ID: 9205745 [TBL] [Abstract][Full Text] [Related]
7. Study of the population of antral G-cells and enterochromaffin-like cells in the rat and mouse gastric mucosa after long-term treatment with ebrotidine. Romero A; Gómez F; Villamayor F; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):520-3. PubMed ID: 9205756 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration. Romero A; Gómez F; Villamayor F; Ballesta A; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757 [TBL] [Abstract][Full Text] [Related]
9. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data. Slomiany BL; Piotrowski J; Slomiany A Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days. Frías J; Esteban C; Carcas AJ; Sánchez-García P; Albet C; Torres J; Márquez M; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759 [TBL] [Abstract][Full Text] [Related]
15. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers. Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766 [TBL] [Abstract][Full Text] [Related]
16. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers. Muñoz-Navas M; Honorato J; Reina-Ariño M; Márquez M; Herrero E; Villamayor F; Torres J; Roset PN; Fíllat O; Camps F; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ebrotidine in rats and dogs. Albet C; Pérez JA; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):483-5. PubMed ID: 9205748 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions. Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767 [TBL] [Abstract][Full Text] [Related]
19. Chronic toxicity of ebrotidine in rats and dogs. Romero A; Grau MT; Villamayor F; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):498-504. PubMed ID: 9205752 [TBL] [Abstract][Full Text] [Related]
20. Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses. Farré M; Roset PN; Badenas JM; Ugena B; Márquez M; Albet C; Herrero E; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):528-30. PubMed ID: 9205758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]